Overview
Sialidosis is a rare autosomal recessive lysosomal storage disorder caused by deficiencies in alpha-N-acetyl neuraminidase (NEU1), leading to the accumulation of sialylated glycoconjugates. It manifests in two types: Type I with later onset and milder symptoms, and Type II with early-onset severe manifestations including systemic organ involvement 13.Diagnosis
Clinical Presentation: Coarse facies, hepatosplenomegaly, refractory ascites, respiratory insufficiency, and cardiovascular dysfunction 13.
Biochemical Tests: Urinary oligosaccharide analysis showing abnormal patterns 3.
Enzyme Assays: Isolated deficiency of alpha-N-acetylneuraminidase (sialidase) in fibroblasts 3.
Molecular Analysis: Genetic mutations in NEU1 or PPCA genes, confirming enzyme complex deficiencies 23.Management
Supportive Care: Intensive care management for respiratory and cardiovascular support 13.
Symptom-Specific Interventions: Addressing ascites and other organ-specific complications as they arise 3.
No Specific Pharmacological Treatment: Current evidence does not support specific drug treatments beyond supportive care 123.Special Populations
Pediatrics: Neonatal cases present with severe symptoms including refractory ascites and early mortality 3.
Cardiovascular Involvement: Early-onset cardiovascular dysfunction noted in neonatal Type II sialidosis 1.Key Recommendations
Genetic Testing for NEU1 and PPCA Mutations: Essential for confirming the diagnosis and understanding the molecular basis (Evidence: Moderate 23).
Comprehensive Multidisciplinary Support: Essential for managing systemic manifestations, particularly in neonates (Evidence: Expert opinion 13).
Monitoring and Management of Cardiovascular Involvement: Early recognition and intervention crucial in Type II sialidosis (Evidence: Weak 1).References
1 Prasanna P, Sriram CS, Rodriguez SH, Kohli U. Cardiovascular involvement in alpha-n-acetyl neuraminidase deficiency syndromes (sialidosis type I and II). Cardiology in the young 2021. link
2 Malvagia S, Morrone A, Caciotti A, Bardelli T, d'Azzo A, Ancora G et al.. New mutations in the PPBG gene lead to loss of PPCA protein which affects the level of the beta-galactosidase/neuraminidase complex and the EBP-receptor. Molecular genetics and metabolism 2004. link
3 Sergi C, Beedgen B, Kopitz J, Zilow E, Zoubaa S, Otto HF et al.. Refractory congenital ascites as a manifestation of neonatal sialidosis: clinical, biochemical and morphological studies in a newborn Syrian male infant. American journal of perinatology 1999. link